In his video commentary, Lp(a) Forum Co-Chair, Professor John Chapman, discusses the key advances in understanding of Lp(a) and its atherogenic properties that put Lp(a) on the map for scientists and clinicians, and he considers the important questions that remain and their implications for future patient care.
Lilly has provided arms’ length sponsorship funding for the Lp(a) Forum Back to Basics Educational Resources but has had no influence or control over the content.
